RGEN
Overvalued by 58.3% based on the discounted cash flow analysis.
Market cap | $6.63 Billion |
---|---|
Enterprise Value | $6.47 Billion |
Dividend Yield | $0 (0%) |
Earnings per Share | $-0.46 |
Beta | 1.21 |
Outstanding Shares | 56,123,000 |
Return on Equity | - |
---|---|
Return on Assets | - |
Return on Invested Capital | - |
P/E Ratio | -261.17 |
---|---|
PEG | -146.38 |
Price to Sales | 11.5 |
Price to Book Ratio | 3.62 |
Enterprise Value to Revenue | 10.01 |
Enterprise Value to EBIT | 317.77 |
Enterprise Value to Net Income | -988 |
Total Debt to Enterprise | 0.08 |
Debt to Equity | 0.27 |
No data
No data